SCHEMBL4895889

SCHEMBL4895889

CCN(c1ccc2sc(-c3ccccc3)nc2c1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
RAB9A P51151 5/20 0.47
HPGD P15428 4/20 0.47
NFKB1 P19838 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
PKM P14618 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 3/20 0.41
LMNA P02545 2/20 0.41
ESR1 P03372 1/20 0.41
ALDH1A1 P00352 4/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
STAT1 P42224 1/20 0.40
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905809 0.91 NPC1 (0.47) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4902828 0.91 LMNA (0.48) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4904080 0.91 NPC1 (0.46) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4904190 0.91 NPC1 (0.46) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4894588 0.84 LMNA (0.48) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4906978 0.83 NFKB1 (0.46) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4902530 0.82 LMNA (0.47) NPC1SMN1; SMN2RAB9AHPGDNFKB1
SCHEMBL4905178 0.81 PTPN1 (0.47) NPC1SMN1; SMN2RAB9AHPGDMEN1
SCHEMBL4905784 0.79 LMNA (0.47) NPC1SMN1; SMN2RAB9AHPGDMEN1
SCHEMBL4902640 0.79 MEN1 (0.46) NPC1SMN1; SMN2RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD NPC1 50/4885SMN1; SMN2 3271/4885RAB9A 2581/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPC1 59/4885SMN1; SMN2 3404/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.